Alglucosidase Alfa (Intravenous Route)

3 imperatives to transform health care in America. You're invited to watch it live

Free

E-newsletter

Subscribe to Housecall

Our weekly general interest
e-newsletter keeps you up to date on a wide variety of health topics.

Sign up now

Alglucosidase Alfa (Intravenous Route)

Drug Information provided by: Micromedex

US Brand Names

  • Lumizyme
  • Myozyme

Description

Alglucosidase alfa injection is an enzyme that treats Pompe disease, which is also called glycogen storage disease type II. Alglucosidase alfa contains a human enzyme called acid alpha-glucosidase. This enzyme helps with the digestion and absorption of glycogen. People with Pompe disease are not able to make enough of this enzyme.

The Lumizyme™ form of this medicine is only available under a special restricted distribution program called Lumizyme™ ACE (Alglucosidase alfa Control and Education) program.

This medicine is available only with your doctor's prescription.

This product is available in the following dosage forms:

  • Powder for Solution
Before Using
DR603275 Portions of this document last updated: Nov. 1, 2012

Source: Drug Information provided by: Micromedex

Copyright © 2013 Thomson Healthcare Inc. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.

Advertisement


Text Size: smaller largerlarger